comparemela.com

Latest Breaking News On - Enzyme acceptor - Page 1 : comparemela.com

OKYO Pharma LTD: OKYO Pharma Limited - Final audited results for the year ended 31 March 2022

LONDON and NEW YORK, Aug. 16, 2022 (GLOBE NEWSWIRE) OKYO Pharma Limited (NASDAQ: OKYO; LSE: OKYO) (the "Company") is pleased to announce its final audited results for the year ended 31 March 2022. Summary of OKYO-101 studies during the last year OK-101

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.